Does LESTAURTINIB Cause Hypertriglyceridaemia? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Hypertriglyceridaemia have been filed in association with LESTAURTINIB. This represents 16.3% of all adverse event reports for LESTAURTINIB.
13
Reports of Hypertriglyceridaemia with LESTAURTINIB
16.3%
of all LESTAURTINIB reports
10
Deaths
5
Hospitalizations
How Dangerous Is Hypertriglyceridaemia From LESTAURTINIB?
Of the 13 reports, 10 (76.9%) resulted in death, 5 (38.5%) required hospitalization.
Is Hypertriglyceridaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LESTAURTINIB. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does LESTAURTINIB Cause?
Febrile neutropenia (23)
Clostridium difficile colitis (10)
Death (10)
Diarrhoea (10)
Enterococcal infection (9)
Sepsis (9)
Bronchiolitis (8)
Candida infection (8)
Hypertension (8)
Klebsiella infection (8)
What Other Drugs Cause Hypertriglyceridaemia?
PEGASPARGASE (399)
VINCRISTINE (373)
METHOTREXATE (372)
DEXAMETHASONE (358)
CYTARABINE (244)
CYCLOPHOSPHAMIDE (191)
QUETIAPINE (181)
MERCAPTOPURINE (176)
PREDNISONE (161)
DAUNORUBICIN (143)